Technical Analysis for MRNA - Moderna, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
18.62 | 0.92% | 0.17 |
MRNA closed up 0.92 percent on Friday, December 13, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| See historical MRNA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.92% | |
| Calm After Storm | Range Contraction | 0.92% | |
| Down 3 Days in a Row | Weakness | 0.92% | |
| Down 4 Days in a Row | Weakness | 0.92% | |
| Down 5 Days in a Row | Weakness | 0.92% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/06/2019
- Sector: Healthcare
- Industry: Biotechnology
Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Cancer Life Sciences Biology RNA Messenger RNA
Cancer Life Sciences Biology RNA Messenger RNA
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 29.79 |
| 52 Week Low | 11.54 |
| Average Volume | 1,404,920 |
| 200-Day Moving Average | 18.14 |
| 50-Day Moving Average | 17.56 |
| 20-Day Moving Average | 19.77 |
| 10-Day Moving Average | 19.51 |
| Average True Range | 0.85 |
| ADX | 26.61 |
| +DI | 16.89 |
| -DI | 22.07 |
| Chandelier Exit (Long, 3 ATRs ) | 18.94 |
| Chandelier Exit (Short, 3 ATRs ) | 20.27 |
| Upper Bollinger Band | 21.51 |
| Lower Bollinger Band | 18.03 |
| Percent B (%b) | 0.17 |
| BandWidth | 17.59 |
| MACD Line | 0.26 |
| MACD Signal Line | 0.62 |
| MACD Histogram | -0.3573 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 19.22 | ||||
| Resistance 3 (R3) | 19.19 | 18.95 | 19.12 | ||
| Resistance 2 (R2) | 18.95 | 18.80 | 18.97 | 19.09 | |
| Resistance 1 (R1) | 18.79 | 18.71 | 18.87 | 18.82 | 19.05 |
| Pivot Point | 18.55 | 18.55 | 18.60 | 18.57 | 18.55 |
| Support 1 (S1) | 18.39 | 18.40 | 18.47 | 18.42 | 18.19 |
| Support 2 (S2) | 18.15 | 18.31 | 18.17 | 18.15 | |
| Support 3 (S3) | 17.99 | 18.15 | 18.12 | ||
| Support 4 (S4) | 18.02 |
